Author:
Pitts Elizabeth G.,Curry Daniel W.,Hampshire Karly N.,Young Matthew B.,Howell Leonard L.
Funder
National Institute of General Medical Sciences
National Institute on Drug Abuse
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Reference144 articles.
1. Acquas E, Pisanu A, Spiga S, Plumitallo A, Zernig G, Di Chiara G (2007) Differential effects of intravenous R,S-(+/−)-3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its S(+)- and R(−)-enantiomers on dopamine transmission and extracellular signal regulated kinase phosphorylation (pERK) in the rat nucleus accumbens shell. J Neurochem 102(1):121–132.
https://doi.org/10.1111/j.1471-4159.2007.04451.x
2. Adamson S, Metzner R (1988) The nature of the MDMA experience and its role in healing, psychotherapy and spiritual practice. ReVision 10:59–72
3. Amoroso T (2015) The psychopharmacology of ±3,4 methylenedioxymethamphetamine and its role in the treatment of posttraumatic stress disorder. J Psychoactive Drugs 00(5):1–8.
https://doi.org/10.1080/02791072.2015.1094156
4. Amoroso T, Workman M (2016) Treating posttraumatic stress disorder with MDMA-assisted psychotherapy: a preliminary meta-analysis and comparison to prolonged exposure therapy. J Psychopharmacol (Oxf, Engl) 30(7):595–600.
https://doi.org/10.1177/0269881116642542
5. Anderson GM, Braun G, Braun U, Nichols DE, Shulgin aT (1978) Absolute configuration and psychotomimetic activity. NIDA Res Monogr: 8–15
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献